Emese Zsiros

10PUBLICATIONS
60CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 28, 2026
Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120.

|Jan 09, 2026
Advancing adoptive T cell therapy in ovarian cancer: barriers, innovations, and emerging platforms.

Gabriel Nascimento De Souza Santos, Celia DeJohn, Suzanne M Hess

|May 16, 2025
Mending the divide: integrating opioid analgesia and immunotherapy for optimal cancer care.

Celia DeJohn, Emese Zsiros

|Mar 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors.

Henry G Withers, Junko Matsuzaki, Mark Long

|Dec 05, 2024
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer.

Spencer R Rosario, Mark D Long, Shanmuga Chilakapati

|Jun 09, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.

Mary L Disis, Sarah F Adams, Jyoti Bajpai

Pageof 2

Frequent Collaborators

5 joint publications

Kunle Odunsi

3 joint publications

Mark Long

2 joint publications

Chetan C Oturkar

2 joint publications

Kevin H Eng